Peter Rhode - Net Worth and Insider Trading

Peter Rhode Net Worth

The estimated net worth of Peter Rhode is at least $65,494 dollars as of 2024-04-29. Peter Rhode is the See Remarks of HCW Biologics Inc and owns about 46,785 shares of HCW Biologics Inc (HCWB) stock worth over $65,494. Details can be seen in Peter Rhode's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Rhode has not made any transactions after 2021-07-22 and currently still holds the listed stock(s).

Transaction Summary of Peter Rhode

To

Peter Rhode Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Rhode owns 1 companies in total, including HCW Biologics Inc (HCWB) .

Click here to see the complete history of Peter Rhode’s form 4 insider trades.

Insider Ownership Summary of Peter Rhode

Ticker Comapny Transaction Date Type of Owner
HCWB HCW Biologics Inc 2021-07-22 See Remarks

Peter Rhode Latest Holdings Summary

Peter Rhode currently owns a total of 1 stock. Peter Rhode owns 46,785 shares of HCW Biologics Inc (HCWB) as of July 22, 2021, with a value of $65,494.

Latest Holdings of Peter Rhode

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HCWB HCW Biologics Inc 2021-07-22 46,785 1.40 65,494

Holding Weightings of Peter Rhode


Peter Rhode Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Rhode has made a total of 1 transactions in HCW Biologics Inc (HCWB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in HCW Biologics Inc is the acquisition of 12,500 shares on July 22, 2021, which cost Peter Rhode around $100,000.

Insider Trading History of Peter Rhode

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Rhode Trading Performance

GuruFocus tracks the stock performance after each of Peter Rhode's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Rhode is -48.22%. GuruFocus also compares Peter Rhode's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Rhode within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter Rhode's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter Rhode

Average Return

-50.1%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.47 -48.22 -57.65 -50.1 -32.43
Relative Return to S&P 500(%) -16.17 -52.28 -58.35 -40.81 -34.35

Peter Rhode Ownership Network

Ownership Network List of Peter Rhode

No Data

Ownership Network Relation of Peter Rhode


Peter Rhode Owned Company Details

What does HCW Biologics Inc do?

Who are the key executives at HCW Biologics Inc?

Peter Rhode is the See Remarks of HCW Biologics Inc. Other key executives at HCW Biologics Inc include director & Chief Executive Officer Hing C Wong , Chief Financial Officer Rebecca Byam , and SVP of Business Development Lee Flowers .

HCW Biologics Inc (HCWB) Insider Trades Summary

Over the past 18 months, Peter Rhode made no insider transaction in HCW Biologics Inc (HCWB). Other recent insider transactions involving HCW Biologics Inc (HCWB) include a net purchase of 212,244 shares made by Rebecca Byam , a net purchase of 4,000 shares made by Gary M Winer , and a net purchase of 8,400 shares made by Hing C Wong .

In summary, during the past 3 months, insiders sold 0 shares of HCW Biologics Inc (HCWB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HCW Biologics Inc (HCWB) were sold and 234,644 shares were bought by its insiders, resulting in a net purchase of 234,644 shares.

HCW Biologics Inc (HCWB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

HCW Biologics Inc Insider Transactions

No Available Data

Peter Rhode Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Rhode. You might contact Peter Rhode via mailing address: C/o Hcw Biologics, Inc., 2929 N Commerce Pkwy, Miramar Fl 33025.

Discussions on Peter Rhode

No discussions yet.